Remove 2013 Remove Funding Remove Invest Remove Research
article thumbnail

Can AI Tools, $76M Lead BlackThorn to Targeted Pysch Drugs?

Xconomy

The new Series B round will give San Francisco-based BlackThorn—a startup spun out of the Scripps Research Institute in 2013—the backing to run human tests of two experimental treatments. One, headed for Phase 2 testing by next year, is being developed for mood or anxiety disorders.

Tool 78
article thumbnail

How TuesdayNights is Helping Women Entrepreneurs Connect With Capital

socalTECH

We actually started the organization in 2013. You've got to do your research, and take the time so you're not meeting with investors who never invest in your sector. That person you network with might be the person who is going to introduce you to the person who is going to fund you. You have to grow your network.

Help 224
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Data Elite | First Venture Lab for Big Data Launched by Andreessen Horowitz, Formation8, Ron Conway & Others

Tech Zulu Event

Venture lab & early stage fund for big data startups and scientists. Founded by Tasso Argyros and Stamos Venios , the lab is Silicon Valley’s first venture lab and early stage fund for big data startups and scientists, complete with working space, support staff That will help build disruptive big data firms.

Netflix 82
article thumbnail

Everything You Need to Know About Hyperloop

Tech.Co

Since 2013, when Elon Musk released his white paper for an emerging mode of transportation using low air pressure within a tube, companies around the world have answered the call to build the next generation of futuristic transportation. million in Series A financing from Sherpa Capital along with three other funds.

SpaceX 100
article thumbnail

13 Ecosystem Builders That Are Boosting Startup Growth

Tech.Co

Still though, when founders are seeking funding, “ 75 percent of the venture capital goes to three states: Massachusetts, New York, and California,” said Steve Case in an interview with Recode. The Case Foundation invests in people and ideas that can change the world. The Case Foundation (Washington, DC).

Startup 140
article thumbnail

After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes?

Xconomy

In three years, Vertex went from having a billion-dollar hepatitis C business to zero—abandoning the research completely. Called sofosbuvir (Sovaldi), the drug won FDA approval in December 2013. Telaprevir’s sales cratered, and Vertex axed 15 percent of its workforce in October 2013. Then it exited HCV research entirely.

Startup 40
article thumbnail

500 Startups Presents Bitcoinference

Tech Zulu Event

The Bitcoinference served as day 1 of 2 for 500 Startups’ “Commercism” series, with an official agenda that covered industry happenings, social dynamics, and a look into the investment environment. The next portion of the discussion moves into investments into Bitcoin: the currency, technology, and in startups in the space.

Startup 104